# Ramipril 10 mg/Day Prevention

> **NCT01053910** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 1012 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT01053910
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2005-07
- **Final completion:** —
- **Target enrollment:** 1012 (ACTUAL)
- **Last updated:** 2010-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053910, "Ramipril 10 mg/Day Prevention". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01053910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*